166 related articles for article (PubMed ID: 36672150)
21. Cholangiocyte-Derived Exosomal Long Noncoding RNA H19 Promotes Hepatic Stellate Cell Activation and Cholestatic Liver Fibrosis.
Liu R; Li X; Zhu W; Wang Y; Zhao D; Wang X; Gurley EC; Liang G; Chen W; Lai G; Pandak WM; Robert Lippman H; Bajaj JS; Hylemon PB; Zhou H
Hepatology; 2019 Oct; 70(4):1317-1335. PubMed ID: 30985008
[TBL] [Abstract][Full Text] [Related]
22. Forkhead box A2 regulates biliary heterogeneity and senescence during cholestatic liver injury in mice‡.
McDaniel K; Meng F; Wu N; Sato K; Venter J; Bernuzzi F; Invernizzi P; Zhou T; Kyritsi K; Wan Y; Huang Q; Onori P; Francis H; Gaudio E; Glaser S; Alpini G
Hepatology; 2017 Feb; 65(2):544-559. PubMed ID: 27639079
[TBL] [Abstract][Full Text] [Related]
23. α7-nAChR Knockout Mice Decreases Biliary Hyperplasia and Liver Fibrosis in Cholestatic Bile Duct-Ligated Mice.
Ehrlich L; O'Brien A; Hall C; White T; Chen L; Wu N; Venter J; Scrushy M; Mubarak M; Meng F; Dostal D; Wu C; Lairmore TC; Alpini G; Glaser S
Gene Expr; 2018 Aug; 18(3):197-207. PubMed ID: 29580318
[TBL] [Abstract][Full Text] [Related]
24. The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics.
You H; Wang L; Bu F; Meng H; Pan X; Li J; Zhang Y; Wang A; Yin N; Huang C; Li J
FASEB J; 2021 Jul; 35(7):e21700. PubMed ID: 34105828
[TBL] [Abstract][Full Text] [Related]
25. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
Fu J; Wu B; Zhong S; Deng W; Lin F
Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
[TBL] [Abstract][Full Text] [Related]
26. PGE
Brea R; Motiño O; Francés D; García-Monzón C; Vargas J; Fernández-Velasco M; Boscá L; Casado M; Martín-Sanz P; Agra N
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):325-337. PubMed ID: 29109031
[TBL] [Abstract][Full Text] [Related]
27. Collagen-binding fibroblast growth factor ameliorates liver fibrosis in murine bile duct ligation injury.
Shi Q; Wei S; Li ZC; Xu J; Li Y; Guo C; Wu X; Shi C; Di G
J Biomater Appl; 2022 Nov; 37(5):918-929. PubMed ID: 35969638
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of Astragaloside prevents cholestatic liver fibrosis through inhibition of Notch signaling activation].
Mu YP; Zhang X; Fan WW; Li XW; Chen GF; Chen JM; Zhang H; Liu P
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):575-582. PubMed ID: 29056006
[No Abstract] [Full Text] [Related]
29. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
[TBL] [Abstract][Full Text] [Related]
30. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
Fernández-Ramos D; Fernández-Tussy P; Lopitz-Otsoa F; Gutiérrez-de-Juan V; Navasa N; Barbier-Torres L; Zubiete-Franco I; Simón J; Fernández AF; Arbelaiz A; Aransay AM; Lavín JL; Beraza N; Perugorria MJ; Banales JM; Villa E; Fraga MF; Anguita J; Avila MA; Berasain C; Iruzibieta P; Crespo J; Lu SC; Varela-Rey M; Mato JM; Delgado TC; Martínez-Chantar ML
Cell Death Dis; 2018 Sep; 9(10):958. PubMed ID: 30237481
[TBL] [Abstract][Full Text] [Related]
31. Adeno-Associated Virus Serotype 2 Vector-Mediated Reintroduction of microRNA-19b Attenuates Hepatic Fibrosis.
Brandon-Warner E; Benbow JH; Swet JH; Feilen NA; Culberson CR; McKillop IH; deLemos AS; Russo MW; Schrum LW
Hum Gene Ther; 2018 Jun; 29(6):674-686. PubMed ID: 29281894
[TBL] [Abstract][Full Text] [Related]
32. Insulin receptor substrate 2 (IRS2) deficiency delays liver fibrosis associated with cholestatic injury.
Villar-Lorenzo A; Rada P; Rey E; Marañón P; Arroba AI; Santamaría B; Sáiz J; Rupérez FJ; Barbas C; García-Monzón C; Valverde ÁM; González-Rodríguez Á
Dis Model Mech; 2019 Jul; 12(7):. PubMed ID: 31262748
[TBL] [Abstract][Full Text] [Related]
33. Coordinated Targeting of Galanin Receptors on Cholangiocytes and Hepatic Stellate Cells Ameliorates Liver Fibrosis in Multidrug Resistance Protein 2 Knockout Mice.
Petrescu AD; Grant S; Williams E; Frampton G; Parks N; Blaney H; Davies M; John R; Reinhart EH; McMillin M; DeMorrow S
Am J Pathol; 2020 Mar; 190(3):586-601. PubMed ID: 31953035
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of microRNA-126 in hepatic stellate cells may affect pathogenesis of liver fibrosis through the NF-κB pathway.
Feng X; Tan W; Cheng S; Wang H; Ye S; Yu C; He Y; Zeng J; Cen J; Hu J; Zheng R; Zhou Y
DNA Cell Biol; 2015 Jul; 34(7):470-80. PubMed ID: 25974152
[TBL] [Abstract][Full Text] [Related]
35. Exogenous Therapeutics of Microrna-29a Attenuates Development of Hepatic Fibrosis in Cholestatic Animal Model through Regulation of Phosphoinositide 3-Kinase p85 Alpha.
Yang YL; Wang FS; Lin HY; Huang YH
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455716
[TBL] [Abstract][Full Text] [Related]
36. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.
Roderburg C; Urban GW; Bettermann K; Vucur M; Zimmermann H; Schmidt S; Janssen J; Koppe C; Knolle P; Castoldi M; Tacke F; Trautwein C; Luedde T
Hepatology; 2011 Jan; 53(1):209-18. PubMed ID: 20890893
[TBL] [Abstract][Full Text] [Related]
37. iRhom2 inhibits bile duct obstruction-induced liver fibrosis.
Sundaram B; Behnke K; Belancic A; Al-Salihi MA; Thabet Y; Polz R; Pellegrino R; Zhuang Y; Shinde PV; Xu HC; Vasilevska J; Longerich T; Herebian D; Mayatepek E; Bock HH; May P; Kordes C; Aghaeepour N; Mak TW; Keitel V; Häussinger D; Scheller J; Pandyra AA; Lang KS; Lang PA
Sci Signal; 2019 Oct; 12(605):. PubMed ID: 31662486
[TBL] [Abstract][Full Text] [Related]
38. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
39. TGF-β Type I Receptor Kinase Inhibitor EW-7197 Suppresses Cholestatic Liver Fibrosis by Inhibiting HIF1α-Induced Epithelial Mesenchymal Transition.
Kim MJ; Park SA; Kim CH; Park SY; Kim JS; Kim DK; Nam JS; Sheen YY
Cell Physiol Biochem; 2016; 38(2):571-88. PubMed ID: 26845171
[TBL] [Abstract][Full Text] [Related]
40. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
